Abstract-Pediatric Central Nervous System (CNS) neoplasms are the second most prevalent tumors of childhood. Further on, prognosis of this type of neoplasms still remain poor and the comprehension of the etiology and pathogenesis of the disease still remains scarce. Several reports have identified microRNAs as significant molecules in the development of central nervous system tumors and propose that they might compose key molecules underlying oncogenesis. In a previous study we have identified several miRNAs, common to different subtypes of pediatric embryonal CNS malignancies as well as, we have identified miRNAs that manifest significant dynamics with respect to their expression and the neoplasmatic subtype. Overall, 19 tumor cases from children diagnosed with embryonal brain tumors were investigated. As controls, children who suffered a sudden death underwent autopsy and were not present with any brain malignancy were used (13 samples of varying localization). Our experimental approach included microarrays covering 1211 miRNAs, which appeared to manifest tumor-specific dynamics. In conclusion, it appeared that certain miRNAs are neoplasm specific and in particular, their expression manifests linear dynamics. Thus, the investigation of miRNA expression in pediatric embryonal brain tumors might contribute towards the discovery of tumor-specific miRNA signatures, which could potentially afford the identification of gene-specific biomarkers related to diagnosis, prognosis and patient targeted therapy, as well as help us understand oncogenetic dynamics.
mortality and long-term morbidity. All embryonal neoplasms are staged as grade IV malignancies and they consist of medulloblastomas (MBs) and atypical teratoid/rhabdoid tumors (AT/RTs), among others [1] . Medulloblastoma is considered the most common malignant brain tumor of childhood, accounting for 20% of cases [2] . Risk stratification based on clinical parameters is insufficient for accurate prognostication [3] . Current treatment options include surgery, chemotherapy and radiotherapy [4] . However, age limitations for the delivery of radiotherapy have been set due to the vulnerability of the developing brain to radiotherapy-induced neurocognitive deficits [5] . Notwithstanding, aggressive multimodal therapy has improved the prognosis for children with MB, nearly one third of patients will eventually succumbed to progressive tumors. AT/RT is a highly malignant CNS tumour consisting of 1-2% of paediatric brain tumours and accounts for at least 10% of CNS tumours in infants, due to the predominance in children younger of 3 years old. The survival of children younger than 3 years of age remains poor, particularly for patients with supratentorial tumours and those with metastatic disease [2] . It can be supratentorial, especially in cerebral hemispheres, or infratentorial, especially in the cerebellar hemispheres, cerellopontine angle and brain stem mainly in children younger than 2 years of age. Prognosis of AT/RT is dismal, while there are no protocols aimed specifically for this type [2] .
Undeniably, thus far, expression profile analysis has revealed several miRNA signatures related to malignant pediatric brain tumors [6] [7] [8] [9] [10] [11] . In a previous work we have examined the expression signatures of pediatric CNS tumors and in the present report we attempted to identify further expression dynamics in those neoplasms [12] .
II. MATERIALS AND METHODS

A. Patients and Tumor Samples
Patient sampling has been reported previously [12] . In brief, in the present study, 19 embryonal tumor samples were studied from children diagnosed with medulloblastomas (MBs) (n=15) or atypical teratoid/rhabdoid tumors (AT/RT) (n=4) diagnosed according to the 2007 WHO criteria [13] . As controls, 13 samples were used; The First-Choice Human Brain Reference RNA was used (Ambion, Austin, TX, USA) and 12 samples were obtained from deceased children who underwent autopsy and were not present with any brain distortion, including the following anatomic locations: cerebellum (n=3), medulla oblongata (n=3), parietal lobe 
B. Experimental Procedure, Bioinformatics and Regression Analyses
Experimental procedures have been previously described in detail [12] . The total gene signals were extracted using the Imagene 6.0 software (Biodiscovery Inc., USA). Data were pre-processed and sorted with Microsoft Excel ® . Probe replicates were combined and the mean was calculated, which was further used for analysis. Filtering was performed based on the signal intensity. Background correction was performed by subtracting the median local background from the median signal intensity as previously reported [15] . Normalization was performed using the quantile normalization algorithm. MicroRNAs were considered to be significantly differentially expressed (DE) if they obtained a p-value<0.05 and an FDR≤0.05. The multiparameter analyses were performed with the MATLAB ® simulation environment (The Mathworks, Inc, Natick, MA). The two tailed student t-test was used to test the mean differences between two groups. Regression was performed using the y=ax+b and y=ax b functions. Venn diagrams were generated with the Venn Diagram Calculator from the Bioinformatics, Evolutionary Genomics Group of the University of Gent 1 .
III. RESULTS
A. Patient Cohort
Patient descriptive statistics have been reported previously [12] . In brief, the patient cohort included 8 males and 11 females, with minimum age of 0.03 years to maximum 10.2 years (mean age 5.65 years). The median age of MB patients was 7.5 years with a male/female ratio of 1:1.The median age for the AT/RT patients was 1.1 years with a male/female ratio of 1:3, and the median age of the non-malignant cohort was 9 years with a male/female ratio of 1:0.
B. Venn Diagrams Between MB and AT/RT Tumors
In our previous study, 113 DEs miRNAs were identified (with a significance level p<0.05 and FDR<0.05) between embryonal tumors (MBs and AT/RTs) as compared to the control group. Overall, a total of 54 miRNAs (47.8%) were over-expressed and 59 miRNAs (52.2%) were downregulated. Among them, 107 miRNAs were characterized as tissue-specific. Venn diagram analysis manifested six miRNAs; miR-34a, miR-548j, miR-607, miR-891a, miR-3191 and miR-3912. Those miRNAs were found to be commonly differentially expressed in both 1 http://bioinformatics.psb.ugent.be/webtools/Venn/ medulloblastomas as well as in teratoid tumors. Specifically, miR-34a, miR-548j, miR-3191 and miR-3912 were over-expressed, whereas miR-607 and miR-891a were under-expressed. This was found to be true for all tested embryonal tumor samples as compared to the control group. The overlapping relationships of the DE miRNAs among both tumor types is presented in Fig. 1 . Among all of them, 6 were co-differentially expressed in both tumor types (4 co-up-regulated and 2 co-down-regulated).
C. Regression Analysis
Venn diagrams showed that specific miRNAs were similarly up-and down-regulated in MBs and AT/RTs. Based on the previously reported expression levels of commonly differentially expressed miRNAs we have tested those miRNAs for their expression dynamics by regressing their expression values and trying to identify a descending or ascending expression pattern. In particular, miR-186* manifested linear expression dynamics (R 2 =0.914) with a descending pattern from AT/RT to control samples ( Fig.  2A) . miR34a and miR-522* manifested also linear expression dynamics (R 2 =0.9013 and R 2 =0.9794 respectively) with a descending pattern from MBs to control samples (Fig. 2B, Fig. 2E ). miR-3681 and miR-382 manifested similarly linear dynamics (R 2 =0.8356 and R 2 =0.9416 respectively) yet descending from control to AT/RT samples (Fig. 2C, Fig. 2D ). Further on, miR-26b was modelled with an exponential function manifesting excellent dynamics (R 2 =0.968) and a descending pattern from GE samples to control samples (Fig. 2F) . Finally, miR-601 and miR-891a manifested similar dynamics (R 2 =0.9802 and R 2 =0.89 respectively) descending from control to GE samples (Fig. 2G, 2H) . Further on, in a previous report we have shown that unsupervised hierarchical clustering algorithms were in position to partly distinguish between the different tumors types (data not shown). In particular, it has been found that germinomas could be distinctively separated by MB and AT/RT tumors, while MBs and AT/RTs formed two distinctive groups. For further details the reader is referred to the work of Braoudaki et al. (2014) , where the results of unsupervised clustering are presented in detail [12] .
IV. DISCUSSION
In the present work we performed miRNA microarray analysis in pediatric patients with embryonal CNS neoplasms to investigate whether the differential expression of miRNA genes manifests dynamics with respect to tumor type. We have identified several miRNAs that were tumorspecific and at the same time we have identified miRNA that were commonly up-and down-regulated in pediatric embryonal CNS tumors. Our final aim was to identify and provide additional evidence regarding potential miRNA expression signatures relative to their dynamics. To the best of our knowledge, few studies have been comparatively focusing on identifying miRNA biomarkers related to MB and AT/RT diagnostics and therapeutics [6, 10, 16, 17] , but also on the possible dynamics that miRNAs could manifest in CNS tumorigenesis. Thus, to our knowledge, this is the first attempt aiding specifically to evaluate an association between miRNA expression pattern dynamics in pediatric MBs and AT/RTs. By performing miRNA microarrays, 113 miRNAs were found to be differentially expressed, between embryonal tumors and control samples. As aforementioned, 107 were tissue-specific and 6 miRNAs were identified to manifest common expression profile between the two tumor types, yet eight miRNAs manifested linear dynamics. In particular, miR-186* appeared to be linearly regulated, while it was upregulated as compared to control samples. In a previous report it has been found that miR-186* is deleted in medulloblastoma [18] , while CRNDE negatively regulates miR-186* and decreases the expression levels of XIAP and PAK7 in gliomas [19] . Similarly, miR-34a manifested similar dynamics. Previous reports set miR034a as a tumor suppressor miRNA in medulloblastoma [20, 21] , while another report defines that miR-34a as a chemoresistance factor [22] . Finally, concerning our findings for miR-3681, miR-382, miR-522* and miR-26b, no other reports have mentioned their role in medulloblastoma and atypical teratoid/rhabdoid tumors. The reverse behavior was observed for miR-601 and miR-891a i.e. those miRNAs were down-regulated as compared to control samples. No previous reports have been found concerning the role of miR-601 and miR-891a in medulloblastoma and atypical teratoid/rhabdoid tumors.
V. CONCLUSION
The current study was shown to provide significant insights into the growing role of several miRNA signatures in pediatric embryonal CNS neoplasms including MBs and AT/RTs. There was good evidence that miRNA signatures could serve as potential markers for tumor subtype and aggression. Further on, the fact that miRNA expression manifested certain dynamics patterns it could imply that they participate in the mechanistic of pediatric CNS tumorigenesis.
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